As biopharmaceuticals continue to dominate the market the need for greater shelf life and protein stability has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing.
Acquisition combines Quotient and SeaView’s complementary customer portfolios strengthening the early phase clinical experience of the combined business.